Literature DB >> 32769164

Correction: Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer.

.   

Abstract

Entities:  

Year:  2020        PMID： 32769164      PMCID： PMC8966981          DOI： 10.1136/ijgc-2019-001012corr2

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN： 1048-891X            Impact factor:   3.437


× No keyword cloud information.
  1 in total

1.  Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer.

Authors:  Jyoti Mayadev; Dmitriy Zamarin; Wei Deng; Heather Lankes; Roisin O'Cearbhaill; Carol A Aghajanian; Russell Schilder
Journal:  Int J Gynecol Cancer       Date:  2019-12-22       Impact factor: 3.437
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.